SCHEMBL30832862

SCHEMBL30832862

c1ccc2c(-c3nc4ccccc4n3-c3ccc4[nH]cnc4c3)ccnc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 1/20 0.46
▸ ACVR1 Q04771 3/20 0.42
▸ RAB9A P51151 3/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ ESR1 P03372 3/20 0.38
▸ ESR2 Q92731 3/20 0.38
▸ AOC2 O75106 1/20 0.38
▸ NFATC1 O95644 1/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ GRM4 Q14833 3/20 0.36
▸ AURKA O14965 1/20 0.35
▸ TTK P33981 1/20 0.35
▸ AURKB Q96GD4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30832844 0.81 CRBN (0.47) CRBNACVR1RAB9ANPC1KDM4E
SCHEMBL20777386 0.81 CRBN (0.47) CRBNACVR1RAB9ANPC1KDM4E
SCHEMBL30832868 0.74 CRBN (0.55) CRBNKDM4EALDH1A1HPGDHSD17B10
SCHEMBL23874010 0.73 ESR1 (0.46) RAB9ANPC1KDM4EALDH1A1HPGD
SCHEMBL20772661 0.72 CRBN (0.55) CRBNACVR1KDM4EALDH1A1HPGD
SCHEMBL24961922 0.68 KDM4E (0.45) ACVR1KDM4EALDH1A1HPGDMAPK1
SCHEMBL13965104 0.67 RECQL (0.52) RAB9AKDM4EALDH1A1HPGDMAPK1
SCHEMBL21081279 0.67 MAPK10 (0.46) RAB9AKDM4EALDH1A1HPGDESR1
SCHEMBL8671615 0.67 HTT (0.54) —
SCHEMBL18999449 0.66 RECQL (0.61) RAB9AKDM4EALDH1A1HPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111315735-B Dihydrobenzimidazolone C4医药公司 2024-03-08 — — CN disclosed
Send feedback